Loading…
MicroPort Medical (Hong Kong) and SRL (owned by Yunfeng Fund III) agreed to jointly fund the acquisition of LivaNova's CRM business for up to $200 million. MicroPort Hong Kong will hold 75% and SRL 25% of the buyer, MicroPort Cardiac Rhythm B.V.
“微创香港及SRL同意向买方出资,以使买方完成收购事项,完成出资后,买方由微创香港以75%及SRL以25%拥有。”beta.zhitongcaijing.com
Summarized from public sources; check the original articles before acting on it.